SCHEMBL10077803

SCHEMBL10077803

CC(=O)c1c(I)[nH]c(C)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 1/20 0.48
BRD4 O60885 3/20 0.46
BRPF1 P55201 2/20 0.46
CREBBP Q92793 2/20 0.46
HSD17B10 Q99714 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39
CLK2 P49760 1/20 0.39
CSNK1G1 Q9HCP0 1/20 0.39
NPSR1 Q6W5P4 2/20 0.37
EP300 Q09472 1/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
PKM P14618 2/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8145766 0.78 CYP1A2 (0.67) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL12031619 0.74 HSD17B10 (0.46) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL2150911 0.71 CYP1A2 (0.57) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL10058644 0.70 HSD17B10 (0.71) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL2735408 0.70 CYP1A2 (0.45) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL10025285 0.70 CYP1A2 (0.45) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL29025896 0.69 CYP1A2 (0.61) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL7482811 0.67 NPSR1 (0.62) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL19149846 0.65 CYP3A4 (0.48) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL21916084 0.64 BRD4 (0.55) CYP1A2CYP3A4BRD4BRPF1CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2468744-A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-27 EP disclosed